IKNA - Ikena Oncology

-

$undefined

N/A

(N/A)

Ikena Oncology NasdaqGM:IKNA Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Location: 645 Summer Street, Boston, MA, 02210, United States | Website: https://ikenaoncology.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-50.5M

Cash

114.1M

Avg Qtr Burn

-9.566M

Short % of Float

1.42%

Insider Ownership

4.55%

Institutional Own.

72.50%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.